DXKW Stock News 22.75 05/13/2014 02:28:34 Wisdomtree Korea Hedged

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wisdomtree Korea Hedged Equity (DXKW) 22.75 $DXKW

Horizons Launches Korean Equity ETF - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:00AM CDT
Horizons is looking to compete in the Korean ETF market with its new fund targeting the KOSPI 200 Index.

Emerging Market ETFs: Any Bright Spots? - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Fri Jan 31, 11:04AM CST
Current sell-off has created some pockets of opportunity for long-term investors.

Emerging Market ETFs: Any Bright Spots Left? - ETF News And Commentary
Neena Mishra - ZACKS - Fri Jan 31, 11:04AM CST
Current sell-off has created some pockets of opportunity for long-term investors.

3 More Hedged ETFs Hit the Market from Deutsche Bank - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Mon Jan 27, 6:31AM CST
Investors now have a few more options in the hedged ETF market.

Inside the New Hedged Korea ETF from WisdomTree - ETF News And Commentary
Eric Dutram - ZACKS - Wed Nov 13, 1:00PM CST
Looking to avoid the impact of the won with a Korea ETF investment? Consider this new hedged WisdomTree ETF.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading